SciMed Biotech Podcast with Karthik Musunuri of Avstera

Breakthroughs in Cancer Immunomodulators with Karthik Musunuri of Avstera

Join us on the SciMed Biotech Podcast where we sit down with Karthik Musunuri, CEO of Avstera Therapeutics. Karthik brings a wealth of experience from big pharma and his own entrepreneurial ventures to his current role, where he's focused on developing new immunomodulators that promise to redefine cancer care.

In this conversation, Karthik shares how his earlier roles, from leading sales teams at Merck to steering vaccine strategy at GSK, laid the groundwork for his latest venture. He details the steps from operating high-complexity labs to steering Avstera through the complex waters of FDA approvals. Now, he’s channeling his energy into Avstera Therapeutics, where groundbreaking work on manipulating tumor micro-environments offers new hope in oncology.

You’ll get an inside look at how Avstera’s partnerships with top research institutions like Georgetown University and the University of Pennsylvania are critical to their mission. Karthik also opens up about the challenges they face in the fast-evolving field of cancer immunotherapy and the milestones they’ve reached that keep their team driven.